iifl-logo

Vanta Bioscience Ltd Share Price

19.08
(-4.98%)
May 9, 2025|12:17:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open19.65
  • Day's High19.65
  • 52 Wk High73.5
  • Prev. Close20.08
  • Day's Low19.08
  • 52 Wk Low 19.7
  • Turnover (lac)0.71
  • P/E0
  • Face Value10
  • Book Value31.35
  • EPS0.02
  • Mkt. Cap (Cr.)12.04
  • Div. Yield0
View All Historical Data
No Records Found

Vanta Bioscience Ltd KEY RATIOS

Sector

FMCG

Open

19.65

Prev. Close

20.08

Turnover(Lac.)

0.71

Day's High

19.65

Day's Low

19.08

52 Week's High

73.5

52 Week's Low

19.7

Book Value

31.35

Face Value

10

Mkt Cap (₹ Cr.)

12.04

P/E

0

EPS

0.02

Divi. Yield

0

Vanta Bioscience Ltd Corporate Action

7 Dec 2024

12:00 AM

EGM

arrow

6 Sep 2024

12:00 AM

AGM

Announcement Date: 06 Sep, 2024

arrow

6 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Vanta Bioscience Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vanta Bioscience Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|09:30 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 69.35%

Foreign: 0.00%

Indian: 69.35%

Non-Promoter- 30.64%

Institutions: 0.00%

Non-Institutions: 30.64%

Custodian: 0.00%

Share Price

Vanta Bioscience Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

6.31

6.31

6.31

6.31

Preference Capital

0

0

0

0

Reserves

13.48

13.43

17.68

17.6

Net Worth

19.79

19.74

23.99

23.91

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

10.03

14.11

3.98

0

yoy growth (%)

-28.87

254.06

0

Raw materials

-0.81

-1.17

-0.32

0

As % of sales

8.15

8.35

8.09

0

Employee costs

-2.82

-4.93

-1.61

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.6

1.28

0.31

0

Depreciation

-1.25

-1.18

-0.57

0

Tax paid

-0.13

-0.31

-0.28

0

Working capital

-4.9

10.76

2.88

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-28.87

254.06

0

Op profit growth

-9.79

318.76

0

EBIT growth

-17.69

532.91

0

Net profit growth

-51.91

3,483.37

0

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

9.72

6.28

9.69

10.04

14.14

Excise Duty

0

0

0

0

0

Net Sales

9.72

6.28

9.69

10.04

14.14

Other Operating Income

0

0

0

0

0

Other Income

0.11

0.69

0.42

0.03

0.11

Vanta Bioscience Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Hindustan Unilever Ltd

HINDUNILVR

2,355.25

53.585,53,387.482,4932.2515,000209.19

Nestle India Ltd

NESTLEIND

2,341.1

72.862,25,718.83885.411.155,447.6442.7

Varun Beverages Ltd

VBL

488.85

65.351,65,322.5678.060.24,052.5348.96

Britannia Industries Ltd

BRITANNIA

5,393.25

61.221,29,906.29557.11.364,218.9115.15

Godrej Consumer Products Ltd

GODREJCP

1,239.85

93.361,26,837.64248.491.612,159.9781.77

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vanta Bioscience Ltd

Management

Register Office

Registrar Office

Managing Director

Dopesh Raja Mulakala

Independent Director

Padmanabhuni Venkata Appaji

Whole Time Director & CEO

Sadhanala Venkata Rao

Addtnl Independent Director

Yogeswara Rao Danda

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name Vanta Bioscience Private Limited. The Company converted into a Public Limited Company and the name was changed to Vanta Bioscience Limited on 17th March 2017.The Company is presently engaged in the business of Preclinical Activities. The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms.The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as Vanta Bioscience (a toxicology division and commenced commercial activities in
Read More

Company FAQs

What is the Vanta Bioscience Ltd share price today?

The Vanta Bioscience Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹19.08 today.

What is the Market Cap of Vanta Bioscience Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vanta Bioscience Ltd is ₹12.04 Cr. as of 09 May ‘25

What is the PE and PB ratio of Vanta Bioscience Ltd?

The PE and PB ratios of Vanta Bioscience Ltd is 0 and 0.64 as of 09 May ‘25

What is the 52 Week High and Low of Vanta Bioscience Ltd?

The 52-week high/low is the highest and lowest price at which a Vanta Bioscience Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vanta Bioscience Ltd is ₹19.7 and ₹73.5 as of 09 May ‘25

What is the CAGR of Vanta Bioscience Ltd?

Vanta Bioscience Ltd's CAGR for 5 Years at -27.46%, 3 Years at -43.44%, 1 Year at -72.68%, 6 Month at -58.18%, 3 Month at -48.38% and 1 Month at 0.70%.

What is the shareholding pattern of Vanta Bioscience Ltd?

The shareholding pattern of Vanta Bioscience Ltd is as follows:
Promoters - 69.36 %
Institutions - 0.00 %
Public - 30.64 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.